Skip to main content
. 2025 Oct 27;17:2441–2457. doi: 10.2147/CMAR.S540752

Figure 1.

Figure 1

Screening of tsRNAs in patients with Colorectal Cancer (CRC). (A) Relative expression levels of two lowly expressed tsRNAs in 20 pairs of CRC tissues. (B) Expression levels of tRF5-23-GlyTCC-2 in 32 pairs of CRC tissues and their corresponding paracancerous tissues. (C) Correlation analysis of tRF5-23-GlyTCC-2 expression levels between 32 CRC tissues and their corresponding serum samples. (D) Expression levels of tRF5-23-GlyTCC-2 in serum samples from CRC patients (n=32) and healthy donors (n=32). (E) Expression levels of tRF5-23-GlyTCC-2 across different CRC cell lines.